# Executive Summary: Next Steps for Biological Countercurvature

## Current State of Evidence
This assessment enforces data integrity and differentiates measured structural evidence from hypothesized narratives regarding the Biological Countercurvature framework. The analysis centers on the `outputs/afcc/2026-02-16/metrics.csv` snapshot and historical run logs.

### What is Stronger Now Than Baseline
1. **Confirmed High-Confidence Tension Nodes:** Candidates like `CNNM2`, `FBLN5`, `STOML3`, and `PIEZO2` exhibit robust, high-anisotropy (> 3.0) and adequate-confidence (pLDDT > 70) structural predictions. These provide the most solid foundation for identifying mechanically resistant architectures.
2. **Identification of Metric Stagnation:** The freshness audit (`reports/evidence_freshness_audit.md`) explicitly identified that many narrative updates over January and February were based on identical, statically reused structural metrics. This prevents future hypothesis inflation and refocuses the project on experimentally verifying existing structures rather than tracking "emerging" clusters.

### What Remains Weak (or Evidence Against Current Hypotheses)
1. **The Structural Role of LBX1:** LBX1 consistently yields low-confidence (pLDDT ~ 66.9) and intermediate-anisotropy (~ 2.27) predictions. While it displays high PAE blockiness, the lack of overall confidence severely weakens the assertion that LBX1 serves as a primary, rigid mechanosensor or core structural node. Its geometry is speculative, undermining its narrative prominence compared to `PIEZO2` or `LMNA`.
2. **Exploratory Outliers:** Highly extended candidates like `POC5` (anisotropy ~ 24.69) and `GHR` (anisotropy ~ 5.13) suffer from low overall modeling confidence (pLDDT < 70). Their status as critical mechanosensors remains a hypothesis lacking structural certainty.
3. **Over-interpreted "Evolution" of Clusters:** Narrative claims detailing the changing roles of LBX1, PIEZO2, and LMNA across runs were falsified by the discovery that their underlying structural metrics had not changed.

## Top 3 Highest-Leverage Next Experiments

1. **Orthogonal Validation of LBX1's Mechanical Role:**
   Conduct the cellular stiffness and LINC complex localization assays (outlined in `reports/lbx1_falsifiability_plan.md`) to establish whether LBX1 responds to or modulates mechanical tension in vivo. This will definitively test its status as a mechanotransducer, circumventing the low-confidence AlphaFold predictions.

2. **Biophysical Profiling of High-Confidence Tension Rods:**
   Prioritize `PIEZO2`, `CNNM2`, and `FBLN5` for in vitro biomechanical testing (e.g., using AFM or magnetic tweezers on reconstituted fragments) to quantify their true stiffness and confirm their load-bearing capacity as "tension rods" in the Countercurvature framework.

3. **Ensemble Modeling of High-Anisotropy/Low-Confidence Outliers:**
   Deploy MD relaxation or advanced ensemble-based structural modeling for `POC5` and `GHR` to determine if their extreme anisotropy is a durable physical feature or merely an artifact of static, low-confidence AlphaFold predictions.
